Therefore, it can be conferred that injection of oligomeric Aβ25-35 (oAβ25-35) could initiate a sequence of harmful events, which includes the induction of endogenous Aβ production and tau hyperphosphorylation resulting in AD-like pathology. The gene discussed is MAPT; the disease is Alzheimer disease.